Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 124

1.

Dose-dependent transitions in mechanisms of toxicity.

Slikker W Jr, Andersen ME, Bogdanffy MS, Bus JS, Cohen SD, Conolly RB, David RM, Doerrer NG, Dorman DC, Gaylor DW, Hattis D, Rogers JM, Setzer RW, Swenberg JA, Wallace K.

Toxicol Appl Pharmacol. 2004 Dec 15;201(3):203-25. Review.

PMID:
15582645
2.

Dose-dependent transitions in mechanisms of toxicity: case studies.

Slikker W Jr, Andersen ME, Bogdanffy MS, Bus JS, Cohen SD, Conolly RB, David RM, Doerrer NG, Dorman DC, Gaylor DW, Hattis D, Rogers JM, Setzer RW, Swenberg JA, Wallace K.

Toxicol Appl Pharmacol. 2004 Dec 15;201(3):226-94. Review.

PMID:
15582646
3.

Next generation testing strategy for assessment of genomic damage: A conceptual framework and considerations.

Dearfield KL, Gollapudi BB, Bemis JC, Benz RD, Douglas GR, Elespuru RK, Johnson GE, Kirkland DJ, LeBaron MJ, Li AP, Marchetti F, Pottenger LH, Rorije E, Tanir JY, Thybaud V, van Benthem J, Yauk CL, Zeiger E, Luijten M.

Environ Mol Mutagen. 2017 Jun;58(5):264-283. doi: 10.1002/em.22045. Epub 2016 Sep 21. Review.

PMID:
27650663
4.

Workshop overview: reassessment of the cancer risk of dichloromethane in humans.

Starr TB, Matanoski G, Anders MW, Andersen ME.

Toxicol Sci. 2006 May;91(1):20-8. Epub 2006 Feb 28.

PMID:
16507920
5.

Harmonization of cancer and noncancer risk assessment: proceedings of a consensus-building workshop.

Bogdanffy MS, Daston G, Faustman EM, Kimmel CA, Kimmel GL, Seed J, Vu V.

Toxicol Sci. 2001 May;61(1):18-31. Review.

PMID:
11294970
6.

Proceedings of the Second Workshop on Theory meets Industry (Erwin-Schrödinger-Institute (ESI), Vienna, Austria, 12-14 June 2007).

Hafner J.

J Phys Condens Matter. 2008 Feb 13;20(6):060301. doi: 10.1088/0953-8984/20/06/060301. Epub 2008 Jan 24.

PMID:
21693862
7.

The fish embryo toxicity test as an animal alternative method in hazard and risk assessment and scientific research.

Embry MR, Belanger SE, Braunbeck TA, Galay-Burgos M, Halder M, Hinton DE, LĂ©onard MA, Lillicrap A, Norberg-King T, Whale G.

Aquat Toxicol. 2010 Apr 15;97(2):79-87. doi: 10.1016/j.aquatox.2009.12.008. Epub 2009 Dec 16. Review.

PMID:
20061034
8.

Risk management frameworks for human health and environmental risks.

Jardine C, Hrudey S, Shortreed J, Craig L, Krewski D, Furgal C, McColl S.

J Toxicol Environ Health B Crit Rev. 2003 Nov-Dec;6(6):569-720. Review.

PMID:
14698953
9.

Proceedings of a workshop on DNA adducts: biological significance and applications to risk assessment Washington, DC, April 13-14, 2004.

Sander M, Cadet J, Casciano DA, Galloway SM, Marnett LJ, Novak RF, Pettit SD, Preston RJ, Skare JA, Williams GM, Van Houten B, Gollapudi BB.

Toxicol Appl Pharmacol. 2005 Oct 1;208(1):1-20.

PMID:
16164957
10.

A public-private consortium advances cardiac safety evaluation: achievements of the HESI Cardiac Safety Technical Committee.

Pierson JB, Berridge BR, Brooks MB, Dreher K, Koerner J, Schultze AE, Sarazan RD, Valentin JP, Vargas HM, Pettit SD.

J Pharmacol Toxicol Methods. 2013 Jul-Aug;68(1):7-12. doi: 10.1016/j.vascn.2013.03.008. Epub 2013 Apr 6.

11.

Approaches and considerations for the assessment of immunotoxicity for environmental chemicals: a workshop summary.

Boverhof DR, Ladics G, Luebke B, Botham J, Corsini E, Evans E, Germolec D, Holsapple M, Loveless SE, Lu H, van der Laan JW, White KL Jr, Yang Y.

Regul Toxicol Pharmacol. 2014 Feb;68(1):96-107. doi: 10.1016/j.yrtph.2013.11.012. Epub 2013 Nov 23.

12.

Need and potential value of the Pig-ain vivo mutation assay-a HESI perspective.

Schuler M, Gollapudi BB, Thybaud V, Kim JH.

Environ Mol Mutagen. 2011 Dec;52(9):685-9. doi: 10.1002/em.20687. Epub 2011 Oct 4.

PMID:
21976154
13.

A call for more integrated cardiovascular safety assessment.

Pettit SD, Berridge B, Sarazan RD.

J Pharmacol Toxicol Methods. 2010 Jan-Feb;61(1):1-2. doi: 10.1016/j.vascn.2009.08.001. Epub 2009 Aug 23.

PMID:
19706331
14.

In silico methods for evaluating human allergenicity to novel proteins: International Bioinformatics Workshop Meeting Report, 23-24 February 2005.

Thomas K, Bannon G, Hefle S, Herouet C, Holsapple M, Ladics G, MacIntosh S, Privalle L.

Toxicol Sci. 2005 Dec;88(2):307-10. Epub 2005 Aug 17.

PMID:
16107555
15.

Human and environmental health challenges for the next decade (2010–2020).

Bonnefoi MS, Belanger SE, Devlin DJ, Doerrer NG, Embry MR, Fukushima S, Harpur ES, Hines RN, Holsapple MP, Kim JH, MacDonald JS, O'Lone R, Pettit SD, Stevens JL, Takei AS, Tinkle SS, van der Laan JW.

Crit Rev Toxicol. 2010 Nov;40(10):893-911. doi: 10.3109/10408444.2010.506640. Review.

PMID:
20854192
16.

Procedures and methods of benefit assessments for medicines in Germany.

Bekkering GE, Kleijnen J.

Eur J Health Econ. 2008 Nov;9 Suppl 1:5-29. doi: 10.1007/s10198-008-0122-5.

PMID:
18987905
18.

Relative sensitivities of toxicity test protocols with the amphipods Eohaustorius estuarius and Ampelisca abdita.

Anderson BS, Lowe S, Phillips BM, Hunt JW, Vorhees J, Clark S, Tjeerdema RS.

Ecotoxicol Environ Saf. 2008 Jan;69(1):24-31. Epub 2007 Jun 18.

PMID:
17572492
19.

Dose-response approaches for nuclear receptor-mediated modes of action for liver carcinogenicity: Results of a workshop.

Andersen ME, Preston RJ, Maier A, Willis AM, Patterson J.

Crit Rev Toxicol. 2014 Jan;44(1):50-63. doi: 10.3109/10408444.2013.835785. Epub 2013 Oct 1. Review.

PMID:
24083384
20.

Supplemental Content

Support Center